These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8183257

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
    Harrison DH, Bohren KM, Petsko GA, Ringe D, Gabbay KH.
    Biochemistry; 1997 Dec 23; 36(51):16134-40. PubMed ID: 9405046
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Aldose reductase as dihydrodiol dehydrogenase. Naphthoquinone formation by rat lens aldose reductase.
    Sato S, Sugiyama K, Carper D.
    Adv Exp Med Biol; 1997 Dec 23; 414():499-505. PubMed ID: 9059655
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics.
    Martin HJ, Breyer-Pfaff U, Wsol V, Venz S, Block S, Maser E.
    Drug Metab Dispos; 2006 Mar 23; 34(3):464-70. PubMed ID: 16381663
    [Abstract] [Full Text] [Related]

  • 28. [Aldose reductase inhibitors].
    Yoneta T, Tagashira E.
    Nihon Rinsho; 1991 Sep 23; 49(9):2017-23. PubMed ID: 1960870
    [No Abstract] [Full Text] [Related]

  • 29. L-Idose: an attractive substrate alternative to D-glucose for measuring aldose reductase activity.
    Balestri F, Cappiello M, Moschini R, Rotondo R, Buggiani I, Pelosi P, Mura U, Del-Corso A.
    Biochem Biophys Res Commun; 2015 Jan 24; 456(4):891-5. PubMed ID: 25528584
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids.
    Endo S, Matsunaga T, Mamiya H, Ohta C, Soda M, Kitade Y, Tajima K, Zhao HT, El-Kabbani O, Hara A.
    Arch Biochem Biophys; 2009 Jul 01; 487(1):1-9. PubMed ID: 19464995
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Catalytic effectiveness of human aldose reductase. Critical role of C-terminal domain.
    Bohren KM, Grimshaw CE, Gabbay KH.
    J Biol Chem; 1992 Oct 15; 267(29):20965-70. PubMed ID: 1400412
    [Abstract] [Full Text] [Related]

  • 34. Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression.
    Zu X, Yan R, Robbins S, Krishack PA, Liao DF, Cao D.
    Toxicol Sci; 2007 Jun 15; 97(2):562-8. PubMed ID: 17329238
    [Abstract] [Full Text] [Related]

  • 35. Aldehyde and aldose reductases from human placenta. Heterogeneous expression of multiple enzyme forms.
    Vander Jagt DL, Hunsaker LA, Robinson B, Stangebye LA, Deck LM.
    J Biol Chem; 1990 Jul 05; 265(19):10912-8. PubMed ID: 2113526
    [Abstract] [Full Text] [Related]

  • 36. Binding energy and specificity in the catalytic mechanism of yeast aldose reductases.
    Nidetzky B, Mayr P, Hadwiger P, Stütz AE.
    Biochem J; 1999 Nov 15; 344 Pt 1(Pt 1):101-7. PubMed ID: 10548539
    [Abstract] [Full Text] [Related]

  • 37. Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase.
    Srivastava SK, Ansari NH, Hair GA, Awasthi S, Das B.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):114-8. PubMed ID: 3083202
    [Abstract] [Full Text] [Related]

  • 38. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism.
    Crosas B, Hyndman DJ, Gallego O, Martras S, Parés X, Flynn TG, Farrés J.
    Biochem J; 2003 Aug 01; 373(Pt 3):973-9. PubMed ID: 12732097
    [Abstract] [Full Text] [Related]

  • 39. Studies on L-threose as substrate for aldose reductase: a possible role in preventing protein glycation.
    Devamanoharan PS, Varma SD.
    Mol Cell Biochem; 1996 Jun 21; 159(2):123-7. PubMed ID: 8858562
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.
    Dhagat U, Endo S, Hara A, El-Kabbani O.
    Bioorg Med Chem; 2008 Mar 15; 16(6):3245-54. PubMed ID: 18165015
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.